Download PDF

Other users also viewed these articles

Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease Carmen Amor Costa; Cristina Suárez Ferrer; Laura García Ramírez; Eduardo Martín-Arranz; Joaquín Poza Cordón; José Luis Rueda García; María Sánchez Azofra; Irene González Diaz; Clara Amiama Roig; María Dolores Martín-Arranz;
Gastroenterol Hepatol. 2025;48:
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11) Natalia García Morales; Sagrario Gutiérrez Morato; Carmen Castillo Cejas; Margarita Fernández de la Varga; Martín Menéndez Rodríguez; Victoria Aguilera; Salvador Benlloch; Luis Menéndez Rodríguez; Teresa Seoane Pillado; Joaquín Cubiella;
Gastroenterol Hepatol. 2025;48:
Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments José Luis Rueda García; José Manuel Benitez; Iria Baston Rey; Margalida Calafat Sard; Cristina Suárez Ferrer;
Gastroenterol Hepatol. 2025;48: